Literature DB >> 25434494

Novel liver findings in ornithine transcarbamylase deficiency due to Xp11.4-p21.1 microdeletion.

Natalie M Gallant1, Dorina Gui2, Charles R Lassman2, William H Yong2, Michael Teitell2, Diana Mandelker3, Fred Lorey4, Julian A Martinez-Agosto5, Fabiola Quintero-Rivera6.   

Abstract

Ornithine transcarbamylase deficiency (OTCD, OMIM 311250), the most common urea cycle disorder, results in impaired synthesis of citrulline from carbamoyl phosphate and ornithine. Individuals have been identified with OTCD due to a contiguous gene deletion at Xp11.4-p21.1 and unique clinical features, described as the "extended OTCD phenotype". We present a male with neonatal-lethal OTCD due to a 1.87Mb microdeletion at Xp11.4-p21.1 (37126841-38998991 hg18). Autopsy revealed a novel histological finding of hepatocyte globular and granular inclusions. Such inclusions have not been described in OTCD or other metabolic disorders and are not an associated finding in neonatal liver failure due to other causes. The deleted region includes the gene SYTL5, potentially involved in RAB27A-dependent membrane trafficking in the liver and placenta. We propose that the contiguous gene deletion could contribute to the severity of the clinical presentation here and hypothesize that deletion of SYTL5 could contribute to the liver findings.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Chromosomal microarray analysis; Hepatocyte inclusions; OTCD; Ornithine transcarbamylase deficiency; Post-analytical tool; SYTL5; Xp11.4, Xp21.1 deletion; Xp11.4-p21.1

Mesh:

Substances:

Year:  2014        PMID: 25434494     DOI: 10.1016/j.gene.2014.11.057

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  1 in total

1.  Involvement of Ornithine Carbamoyltransferase in the Progression of Chronic Hepatitis C and Liver Cirrhosis.

Authors:  Masahiko Ohnishi; Akihisa Higuchi; Hiroshi Matsumura; Yasuo Arakawa; Hitomi Nakamura; Kazushige Nirei; Toshiki Yamamoto; Hiroaki Yamagami; Masahiro Ogawa; Takuji Gotoda; Shunichi Matsuoka; Noriko Nakajima; Masahiko Sugitani; Mitsuhiko Moriyama; Hiroshi Murayama
Journal:  Int J Med Sci       Date:  2017-06-14       Impact factor: 3.738

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.